UNSPSC 51151644: Homatropine

This classification denotes an antimuscarinic agent with the molecular formula C17H24NO3.Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 68JRS2HC1C, chemically known as 8-azoniabicyclo(3.2.1)octane, 3-((hydroxyphenylacetyl)oxy)-8,8-dimethyl-, bromide, endo- but generally known as homatropine methylbromide, which bears US NIH Compound Identifier 6646. European Medicines Agency schedules Homatropine methylbromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08048MIG.

UNSPSC 51151644 Homatropine is a Commodity code that maps to pharmaceutical procurement, though the recent state and local activity under this code does not align with homatropine (an anticholinergic ophthalmic agent) itself. Instead, Seminole County, Florida has posted solicitation IFB60459723LAS seeking naloxone and safe drug deactivation systems—medications and equipment for overdose response and controlled substance disposal rather than diagnostic or therapeutic ophthalmology agents. The mismatch suggests either a tagging error in the county's procurement system or a broader pharmaceutical-supply categorization that encompasses multiple drug families under a single UNSPSC designation. State and local buyers appear to use this code for emergency-response pharmaceuticals and related medical consumables, particularly where community health departments and county health systems are the issuing bodies.

Seminole County is the only recent issuing body visible in the opportunity set. The IFB, posted June 30, 2026, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to the Seminole County Community Health Building in Sanford, Florida; the response deadline was July 26, 2023 (note: the posting date and response date contain an inconsistency in the source). Bidders had to include all shipping and delivery costs, comply with drug-free workplace and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract terms included a two-year initial period with a one-year renewal option and a three-month probationary termination clause. Given the sparse recent-activity record and the code-to-scope mismatch, this code shows minimal recent engagement and may not merit active pursuit unless your firm serves county health systems in naloxone or pharmaceutical-disposal supply chains.